aripiprazole has been researched along with dizocilpine maleate in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 10 (71.43) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Guimarães, FS; Leite, JV; Moreira, FA | 1 |
| Avenet, P; Bergis, O; Boulay, D; Griebel, G | 1 |
| Hashimoto, K; Ishii, D; Iyo, M; Kanahara, N; Kohno, M; Matsuda, S; Matsuzawa, D; Nakazawa, K; Ohtsuka, H; Shimizu, E; Sutoh, C | 1 |
| Abekawa, T; Ito, K; Koyama, T; Nakagawa, S; Nakato, Y | 1 |
| Bojarski, AJ; Duszyńska, B; Grychowska, K; Jastrzębska-Więsek, M; Lenda, T; Marciniec, K; Maślankiewicz, A; Nowak, G; Partyka, A; Pawłowski, M; Satała, G; Siwek, A; Wesołowska, A; Wróbel, D; Zajdel, P | 1 |
| Habata, Y; Imaichi, S; Komatsu, H; Maruyama, M; Mori, M; Sakuma, K | 1 |
| Holahan, MR; Stocco, MR; Tuplin, EW | 1 |
| Amada, N; Deiana, S; Kikuchi, T; Riedel, G; Stott, C; Watanabe, A; Yamasaki, Y | 1 |
| Lorenc-Koci, E; Rogóż, Z; Wąsik, A | 1 |
| Fukuyama, K; Hasegawa, T; Okada, M | 1 |
| Hereta, M; Kamińska, K; Rogóż, Z | 1 |
| Białoń, M; Hereta, M; Kamińska, K; Lorenc-Koci, E; Rogóż, Z; Wąsik, A | 1 |
| Juza, R; Kelemen, E; Korabecny, J; Petrasek, T; Soukup, O; Stuchlik, A; Tuckova, K; Vojtechova, I | 1 |
| Cañete, T; Fernández-Teruel, A; Lavín, V; Oliveras, I; Río-Álamos, C; Sampedro-Viana, D; Sánchez-González, A; Sanna, F; Tapias-Espinosa, C; Tobeña, A; Torrecilla, P | 1 |
14 other study(ies) available for aripiprazole and dizocilpine maleate
| Article | Year |
|---|---|
Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice.
Topics: Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Catalepsy; Central Nervous System Stimulants; Cocaine; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Partial Agonism; Excitatory Amino Acid Antagonists; Glutamine; Haloperidol; Hyperkinesis; Ketamine; Locomotion; Male; Mice; Motor Activity; Piperazines; Quinolones; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Time Factors | 2008 |
The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic mice.
Topics: Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Catalepsy; Clozapine; Disease Models, Animal; Dizocilpine Maleate; Dopamine Plasma Membrane Transport Proteins; Glycine Plasma Membrane Transport Proteins; Hyperkinesis; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Piperazines; Quinolones; Receptors, N-Methyl-D-Aspartate | 2010 |
Effects of aripiprazole on MK-801-induced prepulse inhibition deficits and mitogen-activated protein kinase signal transduction pathway.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Dizocilpine Maleate; Male; Mice; Mitogen-Activated Protein Kinases; Phosphorylation; Piperazines; Quinolones; Reflex, Startle; Signal Transduction | 2010 |
Effects of aripiprazole and haloperidol on progression to schizophrenia-like behavioural abnormalities and apoptosis in rodents.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Antipsychotic Agents; Apoptosis; Aripiprazole; Behavioral Symptoms; Disease Models, Animal; Dizocilpine Maleate; Haloperidol; In Situ Nick-End Labeling; Inhibition, Psychological; Male; Methamphetamine; Microdialysis; Motor Activity; Neuroprotective Agents; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia | 2011 |
Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT₁A/5-HT₂A/5-HT₇ and dopamine D₂/D₃ receptors.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Dizocilpine Maleate; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Isoquinolines; Mice; Molecular Structure; Motor Activity; Piperazines; Quinolines; Quinolones; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Serotonin; Structure-Activity Relationship; Sulfonamides | 2013 |
Temporal and spatial transcriptional fingerprints by antipsychotic or propsychotic drugs in mouse brain.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Dizocilpine Maleate; Gene Expression Profiling; Gene Expression Regulation; Hallucinogens; Haloperidol; Methamphetamine; Mice; Olanzapine; Phencyclidine; Receptors, Dopamine D2 | 2015 |
Attenuation of MK-801-induced behavioral perseveration by typical and atypical antipsychotic pretreatment in rats.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Conditioning, Operant; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Extinction, Psychological; Flupenthixol; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Motor Activity; Prefrontal Cortex; Rats; Rats, Long-Evans | 2015 |
MK-801-induced deficits in social recognition in rats: reversal by aripiprazole, but not olanzapine, risperidone, or cannabidiol.
Topics: Animals; Aripiprazole; Benzodiazepines; Cannabidiol; Dizocilpine Maleate; Dopamine Antagonists; Male; Memory; Models, Animal; Olanzapine; Rats; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Risperidone; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Social Behavior | 2015 |
Combined treatment with aripiprazole and antidepressants reversed some MK-801-induced schizophrenia-like symptoms in mice.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Disease Models, Animal; Dizocilpine Maleate; Drug Synergism; Drug Therapy, Combination; Hyperkinesis; Male; Memory Disorders; Mianserin; Mice; Mirtazapine; Recognition, Psychology; Schizophrenia; Schizophrenic Psychology | 2018 |
Cystine/Glutamate Antiporter and Aripiprazole Compensate NMDA Antagonist-Induced Dysfunction of Thalamocortical L-Glutamatergic Transmission.
Topics: Acetylcysteine; Animals; Antiporters; Aripiprazole; Dizocilpine Maleate; Glutamic Acid; Male; Models, Biological; N-Methylaspartate; Perfusion; Prefrontal Cortex; Rats, Sprague-Dawley; Receptors, GABA-A; Receptors, Metabotropic Glutamate; Synaptic Transmission; Thalamus | 2018 |
Co-treatment with antidepressants and aripiprazole reversed the MK-801-induced some negative symptoms of schizophrenia in rats.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Dizocilpine Maleate; Drug Therapy, Combination; Male; Motor Activity; Rats, Sprague-Dawley; Schizophrenia; Social Behavior | 2019 |
Effect of combined treatment with aripiprazole and antidepressants on the MK-801-induced deficits in recognition memory in novel recognition test and on the release of monoamines in the rat frontal cortex.
Topics: Animals; Antidepressive Agents; Aripiprazole; Benzazepines; Biogenic Monoamines; Citalopram; Dizocilpine Maleate; Dopamine Antagonists; Frontal Lobe; Memory Disorders; Piperazines; Pyridines; Rats; Recognition, Psychology; Serotonin Antagonists | 2020 |
Dopaminergic and glutamatergic models of psychosis show differential sensitivity to aripiprazole and a novel experimental compound modulating D
Topics: Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Psychotic Disorders; Quinolones; Rats; Receptors, Serotonin | 2023 |
Atypical antipsychotics attenuate MK801-induced social withdrawal and hyperlocomotion in the RHA rat model of schizophrenia-relevant features.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Clozapine; Dizocilpine Maleate; Male; Rats; Schizophrenia; Social Isolation | 2023 |